CE, MOC & Certificates

The Genitourinary Cancers Symposium, a multidisciplinary scientific and educational meeting, addresses the needs of those who diagnose, treat, and study genitourinary malignancies. All members of the cancer care and research community, including medical oncologists, surgical oncologists, radiation oncologists, physicians, nurses and others, will benefit from the Symposium’s exploration of the latest science in the field and its clinical application.

Accreditation and Designation Statement

In support of improving patient care, the American Society of Clinical Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

AMA Credit Designation Statement - Physicians

The American Society of Clinical Oncology designates this live activity for AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA/NCCPA Credit Designation Statement – PAs

PAs may claim Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

All non-physician attendees are welcome to submit a request for a Certificate of Participation, which may enable non-physicians to apply their meeting participation toward re-licensure. Please note, however, that all final decisions regarding certificate acceptance will be made by the licensing organization to which the certificate is submitted.

Target Audience

This Symposium is designed for physicians and researchers interested in the prevention, screening, evaluation, and management of genitourinary cancers, including, but not limited to medical, surgical, and radiation oncologists; pathologists; radiologists; and other translational-oriented laboratory scientists.

This Symposium may also benefit nurses, pharmacists, physician assistants, and other health care professionals involved in clinical cancer care and cancer research.

Educational Needs Statement

The Genitourinary Cancers Symposium gives healthcare providers across multiple disciplines and professions the opportunity to receive critical updates and recommendations to improve the care of patients with these cancers. Although incidence and mortality rates continue to increase, emerging science offers new options for multidisciplinary precision care through new and emerging diagnostic approaches, as well as innovative therapy options. Continued evolution in the clinical evidence base highlights the ongoing need for education in this area to ensure that all members of the cancer care team stay current on emerging therapies and diagnostic technologies. 

This program is also designed to provide opportunities for learners to interact with expert faculty of varying disciplines in both the sessions and in active networking events. These dialogues further equip health care providers to deliver optimal care for their patients diagnosed with genitourinary cancers.

Learning Objectives

Upon participation in this activity, attendees will be better able to

  • Collaborate across different specialties and with all members of the oncology care team to provide effective and patient-centered treatment and supportive .
  • Examine the impact of healthcare disparities and differences in treatment standards across different global regions on the outcomes of patients;
  • Consider the benefits and current challenges of implementing multimodality therapy for patients, to include accurate identification of subtypes as well as optimal treatment sequencing;
  • Compare and contrast the disease characteristics that indicate different surgical options, as well as those that indicate that watchful waiting, to determine the best approach based on current evidence in the treatment of each patient;
  • Review where certain diagnostic strategies can help to inform a more precise treatment of patients based on current evidence, including testing for genetic syndromes, molecular characterization of tumors, and the use of novel imaging techniques
  • Outline recommended approaches for less common presentations of cancers in patients.

Disclaimer and Unlabeled Usage Statement

The information presented is that of the contributing faculty and presenters and does not necessarily represent the views of the Symposium Cosponsors and/or any named company or organization providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated by the faculty or presenters.  Therefore, before presenting any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions, and adverse effects.